A randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy, safety and tolerability of ezetimibe 10 mg or placebo added to existing atorvastatin 10 mg or 20 mg in attaining low-density lipoprotein cholesterol target levels in patients with hypercholesterolemia and coronary heart disease.

Next Previous
Trial Profile

A randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy, safety and tolerability of ezetimibe 10 mg or placebo added to existing atorvastatin 10 mg or 20 mg in attaining low-density lipoprotein cholesterol target levels in patients with hypercholesterolemia and coronary heart disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Atorvastatin; Ezetimibe
  • Indications Coronary disorders; Hypercholesterolaemia
  • Focus Therapeutic Use

    • Most Recent Events

    • 19 Oct 2006 Status change
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top